Logos Global Management »

Abivax SA F shares owned by Logos Global Management

Quarter-by-quarter ownership of Abivax SA F (ABVX) shares owned by Logos Global Management from 13F filings

Historical chart of Logos Global Management investment in Abivax SA F

Tip: Access up to 7 years of quarterly data

All positions including Abivax SA F held by Logos Global Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abivax SA F by Logos Global Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $35M 415k 84.90

More positions owned by Logos Global Management

Revolution Medicines Call Option (RVMD)
Ideaya Biosciences Call Option (IDYA)
Akero Therapeutics (AKRO)
Arvinas Ord (ARVN)
Ocular Therapeutix (OCUL)
Cidara Therapeutics Com New (CDTX)
Verastem Com New (VSTM)
Abivax Sa Sponsored Ads (ABVX)
Janux Therapeutics (JANX)
Erasca (ERAS)
Maze Therapeatics (MAZE)
Olema Pharmaceuticals (OLMA)
Immunocore Hldgs Ads (IMCR)
Dyne Therapeutics (DYN)
Disc Medicine (IRON)

View all positions for Logos Global Management

Top funds holding Abivax SA F

TCG Crossover Management
UBS Group
Darwin Global Management
Point72 Asset Management
Cormorant Asset Management
Paradigm Biocapital Advisors
Caligan Partners
FMR
ADAR1 Capital Management
Octagon Capital Advisors
Millennium Management
Vestal Point Capital
Adage Capital Partners GP
Baker Bros. Advisors
Farallon Capital Management

View all funds holding Abivax SA F